Literature DB >> 23392957

Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes.

Karelle Bénardais1, Alexandra Kotsiari, Jelena Skuljec, Paraskevi N Koutsoudaki, Viktoria Gudi, Vikramjeet Singh, Franca Vulinović, Thomas Skripuletz, Martin Stangel.   

Abstract

Cuprizone [bis(cyclohexylidenehydrazide)]-induced toxic demyelination is an experimental animal model commonly used to study de- and remyelination in the central nervous system. In this model, mice are fed with the copper chelator cuprizone which leads to oligodendrocyte death with subsequent demyelination. The underlying mechanisms of cuprizone-induced oligodendrocyte death are still unknown, and appropriate in vitro investigations to study these mechanisms are not available. Thus, we studied cuprizone effects on rat primary glial cell cultures and on the neuroblastoma cell line SH-SY5Y. Treatment of cells with different concentrations of cuprizone failed to show effects on the proliferation and survival of SH-SY5Y cells, microglia, astrocytes, and oligodendrocyte precursor cells (OPC). In contrast, differentiated mature oligodendrocytes (OL) were found to be significantly affected by cuprizone treatment. This was accompanied by a reduced mitochondrial potential in cuprizone-treated OL. These results demonstrate that the main toxic target for cuprizone is mature OL, whilst other glial cells including OPC are not or only marginally affected. This explains the selective demyelination induced by cuprizone in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392957     DOI: 10.1007/s12640-013-9380-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  20 in total

1.  Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg").

Authors:  M Stangel; A Compston; N J Scolding
Journal:  J Neuroimmunol       Date:  2000-03-01       Impact factor: 3.478

2.  The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia.

Authors:  L A Pasquini; C A Calatayud; A L Bertone Uña; V Millet; J M Pasquini; E F Soto
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

Review 3.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

4.  Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone.

Authors:  W F Blakemore
Journal:  J Neurol Sci       Date:  1973-09       Impact factor: 3.181

5.  Cuprizone neurotoxicity, copper deficiency and neurodegeneration.

Authors:  Federico Benetti; Marcello Ventura; Benedetta Salmini; Stefano Ceola; Donatella Carbonera; Stefano Mammi; Andrea Zitolo; Paola D'Angelo; Emanuela Urso; Michele Maffia; Benedetto Salvato; Enzo Spisni
Journal:  Neurotoxicology       Date:  2010-05-26       Impact factor: 4.294

6.  Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.

Authors:  W F Blakemore
Journal:  J Neurocytol       Date:  1972-12

7.  Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment.

Authors:  P Zatta; M Raso; P Zambenedetti; W Wittkowski; L Messori; F Piccioli; P L Mauri; M Beltramini
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

8.  Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration.

Authors:  Sean R Werner; Joy K Saha; Carol L Broderick; Eugene Y Zhen; Richard E Higgs; Kevin L Duffin; Rosamund C Smith
Journal:  J Mol Neurosci       Date:  2010-04-17       Impact factor: 3.444

9.  Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.

Authors:  Maren Lindner; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Neurosci Lett       Date:  2009-02-10       Impact factor: 3.046

10.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  41 in total

1.  IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination.

Authors:  Julian Zimmermann; Michael Emrich; Marius Krauthausen; Simon Saxe; Louisa Nitsch; Michael T Heneka; Iain L Campbell; Marcus Müller
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes.

Authors:  Melisa Herrero; Shir Mandelboum; Orna Elroy-Stein
Journal:  Neuromolecular Med       Date:  2019-05-27       Impact factor: 3.843

3.  Cuprizone Intoxication Induces Cell Intrinsic Alterations in Oligodendrocyte Metabolism Independent of Copper Chelation.

Authors:  Alexandra Taraboletti; Tia Walker; Robin Avila; He Huang; Joel Caporoso; Erendra Manandhar; Thomas C Leeper; David A Modarelli; Satish Medicetty; Leah P Shriver
Journal:  Biochemistry       Date:  2017-02-28       Impact factor: 3.162

Review 4.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

5.  Investigation of Cuprizone Inactivation by Temperature.

Authors:  Sandra Heckers; Nadine Held; Jessica Kronenberg; Thomas Skripuletz; Andre Bleich; Viktoria Gudi; Martin Stangel
Journal:  Neurotox Res       Date:  2017-01-26       Impact factor: 3.911

6.  Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces.

Authors:  Steven M Wellman; Kelly Guzman; Kevin C Stieger; Lauren E Brink; Sadhana Sridhar; Mitchell T Dubaniewicz; Lehong Li; Franca Cambi; Takashi D Y Kozai
Journal:  Biomaterials       Date:  2020-02-06       Impact factor: 12.479

7.  A cord blood monocyte-derived cell therapy product accelerates brain remyelination.

Authors:  Arjun Saha; Susan Buntz; Paula Scotland; Li Xu; Pamela Noeldner; Sachit Patel; Amy Wollish; Aruni Gunaratne; Tracy Gentry; Jesse Troy; Glenn K Matsushima; Joanne Kurtzberg; Andrew E Balber
Journal:  JCI Insight       Date:  2016-08-18

8.  Functional Effects of Cuprizone-Induced Demyelination in the Presence of the mTOR-Inhibitor Rapamycin.

Authors:  Hana Yamate-Morgan; Kelli Lauderdale; Joshua Horeczko; Urja Merchant; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2019-01-29       Impact factor: 3.590

9.  Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.

Authors:  C Guglielmetti; J Veraart; E Roelant; Z Mai; J Daans; J Van Audekerke; M Naeyaert; G Vanhoutte; R Delgado Y Palacios; J Praet; E Fieremans; P Ponsaerts; J Sijbers; A Van der Linden; M Verhoye
Journal:  Neuroimage       Date:  2015-10-23       Impact factor: 6.556

10.  Hippocampal Neurogenesis and Neural Circuit Formation in a Cuprizone-Induced Multiple Sclerosis Mouse Model.

Authors:  Hai Zhang; Yeonghwan Kim; Eun Jeoung Ro; Cindy Ho; Daehoon Lee; Bruce D Trapp; Hoonkyo Suh
Journal:  J Neurosci       Date:  2019-11-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.